Wake Forest University Health Sciences: Carcinoma, Non-Small-Cell Lung trials

The registry lists 36 Carcinoma, Non-Small-Cell Lung studies with Wake Forest University Health Sciences as lead sponsor. 5 are open to participants now and 11 have results posted.

Early Phase 1 1Phase 1 5Phase 2 16Phase 3 1No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative StudyRecruitingNCT06567704
• Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsRecruitingNCT06418204
• Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung CancerRecruitingNCT05696782Phase 2
• Reducing the Incidence of Symptomatic Brain Metastases With MRI SurveillanceRecruitingNCT05692635Phase 2
• Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/ImmunotherapyRecruitingNCT04253964Phase 2
• Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer PatientsTerminatedNCT04398199Phase 2Results posted
• Exhaled Breath Analysis to Predict Risk of Symptomatic PneumonitisTerminatedNCT04040244Not applicableResults posted
• Metabolic and Microbial Profiling of Lung CancerTerminatedNCT03998189Not applicableResults posted
• High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung CancerTerminatedNCT03870529Early Phase 1Results posted
• Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLCActive, not recruitingNCT03141359Phase 2Results posted
• Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic MutationsTerminatedNCT02949843Phase 2Results posted
• Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung CancerCompletedNCT02581943Phase 2Results posted
• Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3CompletedNCT02426658Phase 2Results posted
• Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT01557959Phase 2Results posted
• Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung CancerCompletedNCT01185639Not applicableResults posted
• Radiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT00499447Not applicableResults posted
• Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving ImmunotherapyActive, not recruitingNCT05703269Not applicable
• Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer PatientsActive, not recruitingNCT05415358
• Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung CarcinomaWithdrawnNCT04485026Phase 2
• Paclitaxel Therapeutic Drug Monitoring in Cancer PatientsSuspendedNCT03987555
• Changes in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung CancerCompletedNCT03746262
• CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung CancerWithdrawnNCT03370159Phase 1/2
• Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by SurgeryTerminatedNCT02566421Not applicable
• Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerWithdrawnNCT02014545Phase 2
• Improving Resection Rates Among African Americans With NSCLCCompletedNCT01885455Not applicable
• Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle AspiratesCompletedNCT01630122
• Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung CancerCompletedNCT01457469Phase 1
• Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the BodyWithdrawnNCT01325753Not applicable
• Thermal Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer > 3.5 cm in SizeTerminatedNCT01028612Not applicable
• Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung CancerCompletedNCT01026467
• Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerWithdrawnNCT00471835Phase 1/2
• Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00310154Phase 1
• Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00278460Phase 2
• Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00028938Phase 3
• Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00025285Phase 2
• Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT00003202Phase 1/2